Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)
Others
Ratios

Benitec Biopharma (BNTC) Other Non Operating Income (2019 - 2025)

Benitec Biopharma's Other Non Operating Income history spans 7 years, with the latest figure at -$93000.0 for Q1 2025.

  • For Q1 2025, Other Non Operating Income changed N/A year-over-year to -$93000.0; the TTM value through Mar 2025 reached $764000.0, up 243.88%, while the annual FY2023 figure was -$415000.0, 78.88% down from the prior year.
  • Other Non Operating Income for Q1 2025 was -$93000.0 at Benitec Biopharma, down from $764000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $764000.0 in Q4 2024 and bottomed at -$531000.0 in Q2 2023.
  • The 5-year median for Other Non Operating Income is -$23500.0 (2022), against an average of -$11500.0.
  • The largest annual shift saw Other Non Operating Income plummeted 11100.0% in 2021 before it soared 4144.44% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at $47000.0 in 2021, then skyrocketed by 242.55% to $161000.0 in 2022, then tumbled by 88.82% to $18000.0 in 2023, then skyrocketed by 4144.44% to $764000.0 in 2024, then plummeted by 112.17% to -$93000.0 in 2025.
  • Per Business Quant, the three most recent readings for BNTC's Other Non Operating Income are -$93000.0 (Q1 2025), $764000.0 (Q4 2024), and $93000.0 (Q3 2024).